Invobenitug Also Known as Procizumab (PCZ; AK1967) in Critical Cardiovascular Care

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Shock, Cardiogenic

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Yerevan medical scientific center, Yerevan, Armenia

    Contact: Study coordinator (Harutyun Ghrmajyan, Dr.)
  • Erebouni Mwdical Center, Yerevan, Armenia

    Contact: Study coordinator (Hamlet Hayrapetyan)
  • Heart Center Aalst, AZORG, Aalst, Belgium

    Contact: Study coordinator (Christophe Vandenbriele)
  • University Hospital Saint Pierre, Brussels, Belgium

    Contact: Study coordinator (Antoine Herpain) · antoine.herpain@stpierre-bru.be · +3225354912
  • Ghent University Hospital, Ghent, Belgium

    Contact: Study coordinator (Hanna Schaubroeck, Dr.)
  • University Hospital and Medical Faculty of Pilsen, Pilsen, Czechia

    Contact: Study coordinator (Richard Rokyta)
  • Charles University Motol University Hospital, Prague, Czechia

    Contact: Study coordinator (Petr Ostadal)
  • General University Hospital in Prague - FVN, Prague, Czechia

    Contact: Study coordinator (Jan Bělohlávek) · jan.belohlavek@vfn.cz · 420724371594
  • Institute of Clinical and Experimental Medicine - IKEM, Prague, Czechia

    Contact: Study coordinator (Marek Sramko) · marek.sramko@ikem.cz · +420776246127
  • University Hospital Avicenne AP-HP, Bobigny, France

    Contact: Study coordinator (Adrien Picod) · adrien.picod@gmail.com
  • Département d'anesthésie-réanimation, Dijon, France

    Contact: Study coordinator (Pierre-Grégoire Guinot, PhD, MD)
  • University Hospital Lille - Institut Cœur Poumon, Lille, France

    Contact: Study coordinator (Gilles Lemesle) · gilles.lemesle@chru-lille.fr · 0333 20 44 45 61
  • University Hospital - Dupuytren Limoges, Limoges, France

    Contact: Study coordinator (Bruno Evrard) · bruno.evrard@chu-limoges.fr
  • Regional University Hospital Nancy - Hopitaux de Brabois, Nancy, France

    Contact: Study coordinator (Antoine Kimmoun) · a.kimmoun@chru-nancy.fr · 0033383154079
  • Hôpital Pitié Salpêtrière, Paris, France

    Contact: Study coordinator (Alain Combes, PhD, MD)
  • Lariboisière Hospital AP-HP, Paris, France

    Contact: Study coordinator (Benjamin Choustermann) · Benjamin.chousterman@aphp.fr · 0033149958515
  • Radboud University Medical Center, Nijmegen, Netherlands

    Contact: Study coordinator (Peter Pickkers) · Peter.Pickkers@radboudumc.nl
  • Uniersytecki Szpital Kliniczny w Białystoku, Bialystok, Poland

    Contact: Study coordinator (Agnieszka Tycińska)
  • Uniwersytecki Szpital Kliniczny w Białymstoku, Bialystok, Poland

    Contact: Study coordinator (Agnieszka Tycinska, Prof.)
  • Górnośląskie Centrum Medyczne w Katowicach / Śląski Uniwersytet Medyczny w Katowicach, Katowice, Poland

    Contact: Study coordinator (Maciej Wybraniec)
  • Clinical University Hospital Poznań, Poznan, Poland

    Contact: Study coordinator (Aneta Klotzka) · Aneta.klotzka@usk.poznan.pl
  • J. Mikulicz Radecki Clinical University Hospital Wrocław, Wroclaw, Poland

    Contact: Study coordinator (Jan Biegus) · jan.biegus@uwm.edu.pl · +48 71 736 42 05
  • Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia

    Contact: Study coordinator (Marija Zdravkovic, PhD, MD)
  • Institute for Cardiovascular Diseases of Vojvodina, Kamenitz, Serbia

    Contact: Study coordinator (Sonja Dimic, MD)
  • Clinical Center Niš, Niš, Serbia

    Contact: Study coordinator (Bojan Maricic, Dr.)
Study leads
  • Alexandre Mebazaa, Professor

    Principal Investigator

    Hôpital Lariboisière, Paris France

  • David A. Morrow, MD, MPH

    Principal Investigator

    TIMI study Group (An ARO of Brigham & Women's Hospital and an Affiliate of Harvard Medical School)